[go: up one dir, main page]

MX2011013385A - Metodos para cultivar celulas madre y celulas progenitoras. - Google Patents

Metodos para cultivar celulas madre y celulas progenitoras.

Info

Publication number
MX2011013385A
MX2011013385A MX2011013385A MX2011013385A MX2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A
Authority
MX
Mexico
Prior art keywords
methods
progenitor cells
culturing stem
cells
stem
Prior art date
Application number
MX2011013385A
Other languages
English (en)
Inventor
Cynthia Bamdam
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Publication of MX2011013385A publication Critical patent/MX2011013385A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • G01N33/5759—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente solicitud describe un método para cultivar, expandir o desarrollar células madre o tipo madre o células madre pluripotentes inducidas sobre una superficie, que incluye adherir las células a la superficie a través de un ligando que se une a la superficie y las células.
MX2011013385A 2009-06-11 2010-06-11 Metodos para cultivar celulas madre y celulas progenitoras. MX2011013385A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18631009P 2009-06-11 2009-06-11
US32377910P 2010-04-13 2010-04-13
PCT/US2010/038438 WO2010144887A1 (en) 2009-06-11 2010-06-11 Methods for culturing stem and progenitor cells

Publications (1)

Publication Number Publication Date
MX2011013385A true MX2011013385A (es) 2012-05-29

Family

ID=43306642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013385A MX2011013385A (es) 2009-06-11 2010-06-11 Metodos para cultivar celulas madre y celulas progenitoras.

Country Status (15)

Country Link
US (4) US8535944B2 (es)
EP (3) EP4043552A1 (es)
JP (1) JP2012529890A (es)
KR (4) KR20190122749A (es)
CN (2) CN104293732A (es)
AU (2) AU2010259858A1 (es)
BR (1) BRPI1011127A2 (es)
CA (1) CA2767164C (es)
DO (1) DOP2011000384A (es)
EA (1) EA026732B1 (es)
IL (1) IL216902B (es)
MX (1) MX2011013385A (es)
MY (1) MY157524A (es)
SG (1) SG176801A1 (es)
WO (1) WO2010144887A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1590363A4 (en) 2002-09-09 2006-11-02 Dana Farber Cancer Inst Inc BH3-PEPTIDES AND METHOD FOR THEIR USE
EP2008106A2 (en) 2006-03-31 2008-12-31 Dana-Farber Cancer Institute Methods of determining cellular chemosensitivity
CN101652469B (zh) * 2006-12-06 2014-04-16 米纳瓦生物技术公司 用于鉴定和操作细胞的方法
KR20110069144A (ko) 2008-10-09 2011-06-22 미네르바 바이오테크놀로지 코포레이션 세포내에서 다능성을 유도하기 위한 방법
DK3633025T3 (da) 2009-11-12 2022-12-12 Technion Res & Dev Foundation Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand
WO2011063005A2 (en) 2009-11-17 2011-05-26 Advanced Cell Technology, Inc. Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
CN103068971B (zh) * 2010-06-16 2021-08-31 米纳瓦生物技术公司 重编程癌细胞
EP2686418A4 (en) 2011-03-17 2015-04-22 Minerva Biotechnologies Corp METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS
AU2012253652B2 (en) * 2011-05-09 2017-07-06 Minerva Biotechnologies Corporation Genetically engineered growth factor variants
EP3569607A1 (en) * 2011-05-11 2019-11-20 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
JP6466170B2 (ja) * 2011-10-17 2019-02-06 ミネルバ バイオテクノロジーズ コーポレーション 幹細胞の増殖及び誘導用の培地
CN105164249A (zh) * 2012-07-13 2015-12-16 米纳瓦生物技术公司 用于诱导细胞至较不成熟状态的方法
CN104995518A (zh) * 2012-07-24 2015-10-21 米纳瓦生物技术公司 Nme变体物种表达和抑制
EP2885000A4 (en) * 2012-08-14 2015-12-23 Minerva Biotechnologies Corp STEM CELL IMPROVING THERAPEUTICS
US10393733B2 (en) 2012-09-19 2019-08-27 Dana-Farber Cancer Institute, Inc. Dynamic BH3 profiling
KR20140073215A (ko) * 2012-12-06 2014-06-16 삼성전자주식회사 세포 분리용 조성물, 키트 및 이를 이용한 세포 분리 방법
KR20150121131A (ko) * 2013-02-20 2015-10-28 미네르바 바이오테크놀로지 코포레이션 Ｎｍｅ 저해제 및 ｎｍｅ 저해제의 사용 방법
WO2015035996A1 (en) * 2013-09-11 2015-03-19 Amphidex A/S Cell culture products for adherent cell cultures and manufacture thereof
WO2015042249A1 (en) 2013-09-19 2015-03-26 Dana-Farber Cancer Institute, Inc. Methods of bh3 profiling
TWI746420B (zh) 2014-04-07 2021-11-21 美商密內瓦生物技術公司 抗ｎｍｅ抗體
US10596492B2 (en) * 2014-07-09 2020-03-24 Sudhin Biopharma Particle settling devices
AU2016219350A1 (en) 2015-02-10 2017-08-24 Minerva Biotechnologies Corporation Humanized anti-MUC1* antibodies
CN104630144B (zh) * 2015-02-13 2018-02-13 中国医科大学 一种脐血间充质干细胞的分离及培养方法
CA2983022C (en) 2015-04-27 2023-03-07 Dana-Farber Cancer Institute, Inc. High throughput bh3 profiling: a rapid and scalable technology to bh3 profile on low numbers of cells
WO2017040258A1 (en) * 2015-08-28 2017-03-09 Crawford Keith D Adult stem cell compositions and methods of identification and isolation
US20190022242A1 (en) * 2015-12-22 2019-01-24 Abbvie Stemcentrx Llc Novel anti-mmp16 antibodies and methods of use
EP3652315A4 (en) 2017-07-12 2021-09-01 Exosome Diagnostics, Inc. METHODS FOR ISOLATION AND ENRICHMENT OF EXTRACELLULAR VESICLE POPULATIONS DERIVED FROM BIOFLUIDS, AND ASSOCIATED METHODS OF USE
KR20210003169A (ko) 2018-04-18 2021-01-11 수딘 바이오파마 입자 침강 장치
KR20220016802A (ko) 2019-02-04 2022-02-10 미네르바 바이오테크놀로지 코포레이션 항-nme 항체 및 암 또는 암 전이의 치료 방법
JP7589159B2 (ja) 2019-02-26 2024-11-25 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド ライブセルイメージング（ｌｉｖｅ ｃｅｌｌ ｉｍａｇｉｎｇ）動的ＢＨ３プロファイリング
AU2021236679B2 (en) 2020-03-19 2024-02-15 Sudhin Biopharma Particle settling devices
US12049514B2 (en) 2020-06-08 2024-07-30 Minerva Biotechnologies Corporation Anti-NME antibody and method of treating cancer or cancer metastasis
AU2021297535A1 (en) 2020-06-26 2023-02-16 Minerva Biotechnologies Corporation Anti-NME antibody and method of treating cancer or cancer metastasis
CN119317447A (zh) 2022-04-12 2025-01-14 米纳瓦生物技术公司 抗可变muc1*抗体及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
GB9413029D0 (en) * 1994-06-29 1994-08-17 Common Services Agency Stem cell immobilisation
WO1999047674A2 (en) * 1998-03-18 1999-09-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
ES2302726T3 (es) * 2000-02-24 2008-08-01 Invitrogen Corporation Estimulacion y concentracion simultanea de celulas.
US6797514B2 (en) * 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
WO2002022685A2 (en) * 2000-09-11 2002-03-21 Kufe Donald W Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
CA2430060C (en) 2000-11-27 2015-11-24 Minerva Biotechnologies Corporation Identification and use of cell surface receptor-binding ligands for the diagnosis and treatment of cancer
CA2442531A1 (en) * 2001-03-29 2002-10-10 Ramot University Authority For Applied Research & Industrial Development Ltd. Peptides and antibodies to muc 1 proteins
KR100450578B1 (ko) 2002-03-05 2004-09-30 주식회사 안지오랩 엔엠23 단백질을 유효성분으로 하는, 매트릭스메탈로프로테아제 활성 억제 및 혈관신생 억제용 조성물
US7141369B2 (en) * 2002-04-25 2006-11-28 Semibio Technology, Inc. Measuring cellular metabolism of immobilized cells
WO2003099708A1 (en) * 2002-05-28 2003-12-04 Matsushita Electric Industrial Co., Ltd. Process for producing nanoparticle and nanoparticle produced by the process
EP1537143A2 (en) 2002-09-05 2005-06-08 Cell Center Cologne GmbH Immunogenic muc1 glycopeptides
US20040067585A1 (en) * 2002-10-07 2004-04-08 Yu-Chi Wang Cell cultivation surface and method of making the same
EP1660535A2 (en) 2002-11-27 2006-05-31 Minerva Biotechnologies Corporation Techniques and compositions for the diagnosis and treatment of cancer (muc1)
US20060173171A1 (en) * 2003-08-26 2006-08-03 Bamdad Cynthia C Techniques and compositions for diagnosis and treatment of cancer (muci)
CA2584412C (en) 2004-09-14 2017-05-09 Minerva Biotechnologies Corporation Methods for diagnosis and treatment of cancer
GB0424560D0 (en) * 2004-11-08 2004-12-08 Leuven K U Res & Dev Heart valve tissue engineering
US20060252087A1 (en) * 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
US8859495B2 (en) * 2005-03-30 2014-10-14 Minerva Biotechnologies Corporation Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
WO2006108183A2 (en) 2005-04-05 2006-10-12 Corning Incorporated Label free biosensors and cells
CN101652469B (zh) * 2006-12-06 2014-04-16 米纳瓦生物技术公司 用于鉴定和操作细胞的方法
AU2008216495A1 (en) * 2007-02-09 2008-08-21 Genentech, Inc. Anti-Robo4 antibodies and uses therefor
WO2009042814A1 (en) * 2007-09-25 2009-04-02 Minerva Biotechnologies Corp. Early diagnosis and treatment of drug resistance in muc1-positive cancer

Also Published As

Publication number Publication date
CN102549146A (zh) 2012-07-04
EP3633024A1 (en) 2020-04-08
CN102549146B (zh) 2016-01-13
CN104293732A (zh) 2015-01-21
EP2440652A1 (en) 2012-04-18
US20220252604A1 (en) 2022-08-11
EA026732B1 (ru) 2017-05-31
CA2767164A1 (en) 2010-12-16
KR20120025601A (ko) 2012-03-15
US20100316688A1 (en) 2010-12-16
KR20210019599A (ko) 2021-02-22
KR20170075023A (ko) 2017-06-30
DOP2011000384A (es) 2012-12-15
US20140044696A1 (en) 2014-02-13
AU2016204735B2 (en) 2018-05-17
EA201290003A1 (ru) 2012-09-28
US8535944B2 (en) 2013-09-17
EP2440652A4 (en) 2013-05-29
SG176801A1 (en) 2012-01-30
WO2010144887A1 (en) 2010-12-16
CA2767164C (en) 2019-10-15
JP2012529890A (ja) 2012-11-29
IL216902A0 (en) 2012-02-29
EP4043552A1 (en) 2022-08-17
BRPI1011127A2 (pt) 2017-06-06
US20250067746A1 (en) 2025-02-27
AU2010259858A1 (en) 2012-02-02
MY157524A (en) 2016-06-15
AU2016204735A1 (en) 2016-07-28
EP2440652B1 (en) 2019-11-27
KR20190122749A (ko) 2019-10-30
IL216902B (en) 2019-11-28

Similar Documents

Publication Publication Date Title
MX2011013385A (es) Metodos para cultivar celulas madre y celulas progenitoras.
NI201400061A (es) Anticuerpos anti - phf - tau y sus usos
CR20150049A (es) Anticuerpos e inmunoconjugados anti-cd79b
UY33124A (es) Agentes y epítopos enlazados a wise
CR20160206A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5
CO7151527A2 (es) Anticuerpos anti-cd79 b e inmunoconjugados
BRPI0921799A2 (pt) compostos que expandem células-tronco hematopoéticas
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
BRPI0907008A2 (pt) Métodos otimizados para liberação de dsrna alvejando o gene pcsk9
CR20120371A (es) Antagonistas de pcsk9
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
CL2009001263S1 (es) Maquina de afeitar.
UY34537A (es) Composiciones y métodos para anticuerpos que actúan sobre el factor p
EP2793751A4 (en) PLATFORMS FOR MITRALKLAPPENERSATZ
UY4211Q (es) Pizarra para marcadores
CR20140212A (es) Anticuerpos anti-htra1 y métodos de uso
UY4153Q (es) Batería
GB201321365D0 (en) Methods for performing patterned chemistry
BR112013029498A2 (pt) “método para produzir um suíno geneticamente modificado.”
DOP2013000293A (es) Composiciones líquidas de limpieza de sal
BR112012013418A2 (pt) marcador sérico bioquímico.
BRPI1008977A2 (pt) anticorpo para pcrv humanizado que possui atividade anti-pseudomonal
BRPI1008674A2 (pt) Métodos de redução do desenvolvimento de pragas resistentes.
AR096154A1 (es) Colorantes bisazoicos alcoxilados
BRPI1009227A2 (pt) Microorganismos que produz l-aminoácido e método para a produção de l-aminoácido com o uso do mesmo.

Legal Events

Date Code Title Description
FG Grant or registration